239: 2022 in review, CEO indictments, & the year ahead
We look back on the biggest biotech stories of 2022 and how, despite some meaningful advances in Alzheimer's disease and gene therapy, the industry seems stuck in a sentiment rut. We also discuss the ...
22 Des 202229min
238: Leaky health data, ASH22, & what it takes to get booed by your peers
Katie Palmer, STAT's health tech correspondent, joins us to explain how the explosive popularity of telehealth is putting sensitive patient information into the hands of Facebook, TikTok, and other bi...
15 Des 202236min
237: The 'electric vehicles' of pharma, Illumina's boondoggle, & a Theranos sentencing
STAT's Elaine Chen joins us to explain how the escalating demand for a potent diabetes drug is putting patients with obesity in a difficult situation. We also discuss a curious trend in biotech invest...
8 Des 202235min
236: Wither PhRMA, Alzheimer's treatment data revealed, and the first fecal microbiome drug approval
STAT Washington correspondent Rachel Cohrs joins us to explain how PhRMA, the all-powerful lobbying group, lost its edge in a fight over drug-pricing negotiation. Damian gives us the inside scoop on C...
1 Des 202233min
235: LIVE from the STAT Summit
How do Alzheimer’s drugs even work? Can biotech people bake? And do we even like one another? Recorded live from the 2022 STAT Summit, we discuss the failure of an Alzheimer’s disease treatment from R...
17 Nov 202228min
234: Biogen's new CEO, how the midterms affect science, & a biotech bankruptcy
STAT Washington correspondent Sarah Owermohle joins us to explain how this week's midterm elections will affect health and medicine, and what the politicization of the pandemic means for the future of...
10 Nov 202232min
233: How the biotech revolution could come apart at the seams
Our colleague Matthew Herper joins us to discuss his thoughtful, personal story on how the biotech revolution that brought us genome editing, Covid-19 vaccines, and lifesaving medicines could run agro...
3 Nov 202229min
232: Anti-science at the polls, a biotech odd couple, & the stakes of the midterms
Our colleague Sarah Owermohle joins us to discuss how pandemic shutdowns, Covid-19 vaccines, and the prospect of arresting Anthony Fauci have become campaign rallying cries in midterm elections. We al...
27 Okt 202223min
